These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 33508692)
1. Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample. Krawczyk N; Garrett B; Ahmad NJ; Patel E; Solomon K; Stuart EA; Saloner B Drug Alcohol Depend; 2021 Mar; 220():108512. PubMed ID: 33508692 [TBL] [Abstract][Full Text] [Related]
2. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. Flanagan Balawajder E; Ducharme L; Taylor BG; Lamuda PA; Kolak M; Friedmann PD; Pollack HA; Schneider JA JAMA Netw Open; 2024 Sep; 7(9):e2434704. PubMed ID: 39316401 [TBL] [Abstract][Full Text] [Related]
3. Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review. Pilarinos A; Bromberg DJ; Karamouzian M JAMA Pediatr; 2022 Mar; 176(3):304-311. PubMed ID: 34870707 [TBL] [Abstract][Full Text] [Related]
4. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650 [TBL] [Abstract][Full Text] [Related]
5. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare. Gibbons JB; McCullough JS; Zivin K; Brown ZY; Norton EC J Subst Use Addict Treat; 2024 Feb; 157():209271. PubMed ID: 38135120 [TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership. Burke KN; Krawczyk N; Li Y; Byrne L; Desai IK; Bandara S; Feder KA J Subst Use Addict Treat; 2024 Jul; 162():209351. PubMed ID: 38499248 [TBL] [Abstract][Full Text] [Related]
7. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019. Mauro PM; Gutkind S; Annunziato EM; Samples H JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762 [TBL] [Abstract][Full Text] [Related]
8. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198 [TBL] [Abstract][Full Text] [Related]
9. Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives. Venner KL; Donovan DM; Campbell ANC; Wendt DC; Rieckmann T; Radin SM; Momper SL; Rosa CL Addict Behav; 2018 Nov; 86():111-117. PubMed ID: 29914717 [TBL] [Abstract][Full Text] [Related]
10. Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities. Cantor J; Griffin BA; Levitan B; Mendon-Plasek SJ; Stein BD; Hunter SB; Ober AJ JAMA Netw Open; 2024 Jun; 7(6):e2417545. PubMed ID: 38888921 [TBL] [Abstract][Full Text] [Related]
11. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity. Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968 [TBL] [Abstract][Full Text] [Related]
12. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities. Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922 [No Abstract] [Full Text] [Related]
13. Drug court utilization of medications for opioid use disorder in high opioid mortality communities. Marlowe DB; Theiss DS; Ostlie EM; Carnevale J J Subst Abuse Treat; 2022 Oct; 141():108850. PubMed ID: 35931014 [TBL] [Abstract][Full Text] [Related]
14. Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022. Meyerson BE; Treiber D; Brady BR; Newgass K; Bondurant K; Bentele KG; Samorano S; Arredondo C; Stavros N J Subst Use Addict Treat; 2024 May; 160():209306. PubMed ID: 38296033 [TBL] [Abstract][Full Text] [Related]
15. With socioeconomic status controlled, cigarette use is lower among American Indians/Alaska Natives than whites. Cunningham JK; Ritchey J; Arambula Solomon TG Drug Alcohol Depend; 2020 Jun; 211():107836. PubMed ID: 32145982 [TBL] [Abstract][Full Text] [Related]
16. Methamphetamine use among American Indians and Alaska Natives in the United States. Coughlin LN; Lin LA; Jannausch M; Ilgen MA; Bonar EE Drug Alcohol Depend; 2021 Oct; 227():108921. PubMed ID: 34333282 [TBL] [Abstract][Full Text] [Related]
17. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679 [TBL] [Abstract][Full Text] [Related]
18. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170 [TBL] [Abstract][Full Text] [Related]
19. Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs. Tsui JI; Whitney BM; Korthuis PT; Chan B; Pho MT; Jenkins WD; Young AM; Cooper HLF; Friedmann PD; Stopka TJ; de Gijsel D; Miller WC; Go VF; Westergaard R; Brown R; Seal DW; Zule WA; Feinberg J; Smith GS; Mixson LS; Fredericksen R; Crane HM; Delaney JA; Drug Alcohol Depend; 2023 Sep; 250():110911. PubMed ID: 37549545 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S. Curran L; Manuel J Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]